ACER Market Cap History
Below is a table of the ACER market cap history going back to 9/21/2017:

Date ACER Market Cap
9/21/20177.25M
11/1/2017114.50M
3/1/2018129.86M
5/1/2018141.93M
8/10/2018280.38M
10/31/2018227.00M
3/1/2019238.06M
5/1/2019192.67M
8/1/201927.46M

Also see: ACER Shares Outstanding History
and ACER YTD Return
ACER Historical Market Cap:
+104.53% CAGR
ACER Historical Market Cap: +104.53% CAGR

Mouse over chart for data details
9/21/201711/1/20173/1/20185/1/20188/10/201810/31/20183/1/20195/1/20198/1/2019
Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with unmet medical need. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of various neuroendocrine disorders. We show 9 historical shares outstanding datapoints in our ACER shares outstanding history coverage, used to compute ACER market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACER market cap history over the course of time is important for investors interested in comparing ACER's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACER versus a peer is one thing; comparing ACER market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACER can fluctuate over the course of history. With this page we aim to empower investors researching ACER by allowing them to research the ACER market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACER:
ACER SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acer Therapeutics (ACER) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACET Market Cap History
ACHC Market Cap History
ACHN Market Cap History
ACHV Market Cap History
ACOR Market Cap History
ACRS Market Cap History
ACRX Market Cap History
ACST Market Cap History
ADMA Market Cap History
ADMP Market Cap History
More Healthcare companies »

 

ACER Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.